Common Contracts
6 similar Non-Qualified Stock Option Agreement contracts by Acadia Healthcare Company, Inc., CM Life Sciences II Inc., Coskata, Inc., others
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE ADS-TEC ENERGY PUBLIC LIMITED COMPANY 2021 OMNIBUS INCENTIVE PLANNon-Qualified Stock Option Agreement • November 10th, 2021 • European Sustainable Growth Acquisition Corp. • Blank checks • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Ads-Tec Energy Public Limited Company,, an Irish public limited company duly incorporated under the laws of Ireland (the “Company”), and the Participant specified above, pursuant to the Ads-Tec Energy Public Limited Company, 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE SOMALOGIC, INC. 2021 OMNIBUS INCENTIVE PLANNon-Qualified Stock Option Agreement • June 25th, 2021 • CM Life Sciences II Inc. • Services-commercial physical & biological research • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE INTERNATIONAL GENERAL INSURANCE HOLDINGS LTD. 2020 OMNIBUS INCENTIVE PLANNon-Qualified Stock Option Agreement • June 3rd, 2020 • International General Insurance Holdings Ltd. • Insurance carriers, nec • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between International General Insurance Holdings Ltd., a Bermuda exempted company (the “Company”), and the Participant specified above, pursuant to the International General Insurance Holdings Ltd. 2020 Omnibus Incentive Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE COSKATA, INC. 2012 INCENTIVE COMPENSATION PLANNon-Qualified Stock Option Agreement • March 27th, 2012 • Coskata, Inc. • Industrial organic chemicals • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Coskata, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the Coskata, Inc. 2012 Incentive Compensation Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE ACADIA HEALTHCARE COMPANY, INC. 2011 INCENTIVE COMPENSATION PLANNon-Qualified Stock Option Agreement • September 8th, 2011 • Acadia Healthcare Company, Inc. • Services-specialty outpatient facilities, nec • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Acadia Healthcare Company, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the Acadia Healthcare Company, Inc. 2011 Incentive Compensation Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
NON-QUALIFIED STOCK OPTION AGREEMENT PURSUANT TO THE SAGENT PHARMACEUTICALS, INC. 2011 INCENTIVE COMPENSATION PLANNon-Qualified Stock Option Agreement • April 6th, 2011 • Sagent Holding Co. • Pharmaceutical preparations • Delaware
THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between Sagent Pharmaceuticals, Inc., a corporation organized in the State of Delaware (the “Company”), and the Participant specified above, pursuant to the Sagent Pharmaceuticals, Inc. 2011 Incentive Compensation Plan, as in effect and as amended from time to time (the “Plan”), which is administered by the Committee; and
